Literature DB >> 18207302

Progress in neuroprotective strategies for preventing epilepsy.

Munjal M Acharya1, Bharathi Hattiangady, Ashok K Shetty.   

Abstract

Neuroprotection is increasingly considered as a promising therapy for preventing and treating temporal lobe epilepsy (TLE). The development of chronic TLE, also termed as epileptogenesis, is a dynamic process. An initial precipitating injury (IPI) such as the status epilepticus (SE) leads to neurodegeneration, abnormal reorganization of the brain circuitry and a significant loss of functional inhibition. All of these changes likely contribute to the development of chronic epilepsy, characterized by spontaneous recurrent motor seizures (SRMS) and learning and memory deficits. The purpose of this review is to discuss the current state of knowledge pertaining to neuroprotection in epileptic conditions, and to highlight the efficacy of distinct neuroprotective strategies for preventing or treating chronic TLE. Although the administration of certain conventional and new generation anti-epileptic drugs is effective for primary neuroprotection such as reduced neurodegeneration after acute seizures or the SE, their competence for preventing the development of chronic epilepsy after an IPI is either unknown or not promising. On the other hand, alternative strategies such as the ketogenic diet therapy, administration of distinct neurotrophic factors, hormones or antioxidants seem useful for preventing and treating chronic TLE. However, long-term studies on the efficacy of these approaches introduced at different time-points after the SE or an IPI are lacking. Additionally, grafting of fetal hippocampal cells at early time-points after an IPI holds considerable promise for preventing TLE, though issues regarding availability of donor cells, ethical concerns, timing of grafting after SE, and durability of graft-mediated seizure suppression need to be resolved for further advances with this approach. Overall, from the studies performed so far, there is consensus that neuroprotective strategies need to be employed as quickly as possible after the onset of the SE or an IPI for considerable beneficial effects. Nevertheless, ideal strategies that are capable of facilitating repair and functional recovery of the brain after an IPI and preventing the evolution of IPI into chronic epilepsy are still hard to pin down.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18207302      PMCID: PMC2441599          DOI: 10.1016/j.pneurobio.2007.10.010

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  501 in total

1.  Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover.

Authors:  Patrick G Sullivan; Natasa B Dragicevic; Jian-Hong Deng; Yidong Bai; Edgardo Dimayuga; Qunxing Ding; Qinghua Chen; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  J Biol Chem       Date:  2004-01-22       Impact factor: 5.157

2.  Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy.

Authors:  W T Lee; Y Z Shen; C Chang
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  Excitatory synaptic potentials in kainic acid-denervated rat CA1 pyramidal neurons.

Authors:  D A Turner; H V Wheal
Journal:  J Neurosci       Date:  1991-09       Impact factor: 6.167

4.  Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid.

Authors:  J V Nadler; B W Perry; C Gentry; C W Cotman
Journal:  J Comp Neurol       Date:  1980-07-15       Impact factor: 3.215

5.  Efficacy of the ketogenic diet for infantile spasms.

Authors:  Eric H Kossoff; Paula L Pyzik; Jane R McGrogan; Eileen P G Vining; John M Freeman
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

6.  Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy.

Authors:  D G Fujikawa; H H Itabashi; A Wu; S S Shinmei
Journal:  Epilepsia       Date:  2000-08       Impact factor: 5.864

7.  The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively.

Authors:  C Hemingway; J M Freeman; D J Pillas; P L Pyzik
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

Review 8.  Moderate hypothermia in the management of severe traumatic brain injury: a good idea proved ineffective?

Authors:  J Sahuquillo; M P Mena; A Vilalta; M A Poca
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

9.  Hippocampal mossy fiber sprouting and synapse formation after status epilepticus in rats: visualization after retrograde transport of biocytin.

Authors:  M M Okazaki; D A Evenson; J V Nadler
Journal:  J Comp Neurol       Date:  1995-02-20       Impact factor: 3.215

Review 10.  Cell protective role of melatonin in the brain.

Authors:  D Acuña-Castroviejo; G Escames; M Macías; A Muñóz Hoyos; A Molina Carballo; M Arauzo; R Montes
Journal:  J Pineal Res       Date:  1995-09       Impact factor: 13.007

View more
  50 in total

Review 1.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Small molecule anticonvulsant agents with potent in vitro neuroprotection.

Authors:  Douglas E Brenneman; Garry R Smith; Yan Zhang; Yanming Du; Sandeep K Kondaveeti; Michael J Zdilla; Allen B Reitz
Journal:  J Mol Neurosci       Date:  2012-04-26       Impact factor: 3.444

3.  The effect of vitamin U on the lung tissue of pentyleneterazole-induced seizures in rats.

Authors:  Sehkar Oktay; Gamze Bayrak; Burcin Alev; Hazal Ipekci; Unsal Veli Ustundag; Ismet Burcu Turkyilmaz; Rabia Pisiriciler; Ebru Emekli-Alturfan; Tugba Tunali-Akbay; Refiye Yanardag; Aysen Yarat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-07       Impact factor: 3.000

4.  P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control.

Authors:  Tobias Engel; Alba Jimenez-Pacheco; Maria Teresa Miras-Portugal; Miguel Diaz-Hernandez; David C Henshall
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

Review 5.  Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection?

Authors:  Ashok K Shetty
Journal:  Epilepsy Behav       Date:  2014-01-13       Impact factor: 2.937

6.  Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat.

Authors:  Panagiota Miltiadous; Antonios Stamatakis; Fotini Stylianopoulou
Journal:  Cell Mol Neurobiol       Date:  2009-09-24       Impact factor: 5.046

7.  Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells.

Authors:  Munjal M Acharya; Lori-Ann Christie; Mary L Lan; Peter J Donovan; Carl W Cotman; John R Fike; Charles L Limoli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

8.  Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy.

Authors:  Mustafa Nazıroglu
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 9.  Finding a better drug for epilepsy: antiepileptogenesis targets.

Authors:  Katja Kobow; Stéphane Auvin; Frances Jensen; Wolfgang Löscher; Istvan Mody; Heidrun Potschka; David Prince; Alejandra Sierra; Michele Simonato; Asla Pitkänen; Astrid Nehlig; Jong M Rho
Journal:  Epilepsia       Date:  2012-10-12       Impact factor: 5.864

10.  Effect of different mild hypoxia manipulations on kainic acid-induced seizures in the hippocampus of rats.

Authors:  Yang Yang; Jianhua Chen; Li Li; Yusong Gao; Jun Chen; Zhou Fei; Weiping Liu
Journal:  Neurochem Res       Date:  2012-10-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.